Fingerprint
Dive into the research topics of 'Impact of the 12-gene colon cancer assay on clinical decision making for adjuvant therapy in stage II colon cancer patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Impact of the 12-gene colon cancer assay on clinical decision making for adjuvant therapy in stage II colon cancer patients
Baruch Brenner*, Ravit Geva, Megan Rothney, Alexander Beny, Ygael Dror, Mariana Steiner, Ayala Hubert, Efraim Idelevich, Alexander Gluzman, Ofer Purim, Einat Shacham-Shmueli, Katerina Shulman, Moshe Mishaeli, Sophia Man, Lior Soussan-Gutman, Haluk Tezcan, Calvin Chao, Adi Shani, Nicky Liebermann
*Corresponding author for this work
- Tel Aviv Sourasky Medical Center
- Genomic Health Inc.
- Rambam Health Care Campus Israel
- Meir Hospital Sapir Medical Center
- Carmel Medical Center
- Hadassah University Medical Centre
- Kaplan Medical Center Israel
- Soroka Medical Center
- Tel Aviv University
- Sheba Medical Center at Tel Hashomer
- Hille Yaffe Medical Center Israel
- Teva Pharmaceutical Industries Ltd.
- Clalit Health Services
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations